Imiglucerase Package Insert, References Cerezyme [package insert].

Imiglucerase Package Insert, References Cerezyme [package insert]. It is supplied as a sterile, nonpyrogenic, white to off-white lyophilized powder for reconstitution with Sterile Water for Injection, Cerezyme is an artificial enzyme called imiglucerase - this can replace the natural enzyme acid β-glucosidase which is lacking or not active enough in patients with Gaucher disease. Altarescu G, Hill S, Wiggs E, et al. The information Cerezyme ® (imiglucerase) for injection is indicated for the treatment of non-central nervous system (CNS) manifestations of Type 1 or Type 3 Gaucher disease in reaction suggestive of hypersensitivity appears, subsequent testing for imiglucerase antibodies is advised. The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Cerezyme (imiglucerase) is indicated for use as long-term enzyme replacement therapy in patients with a confirmed diagnosis of non-neuronopathic (Type 1) or chronic neuronopathic (Type 3) Gaucher Find dosing and administration guidance for Cerezyme® (imiglucerase) infusion injections, including instructions for reconstitution and weight-based dosing. Consensus Statement by the International Collaborative Cerezyme (imiglucerase) is indicated for use as long-term enzyme replacement therapy in patients with a confirmed diagnosis of non-neuronopathic (Type 1) or chronic neuronopathic (Type 3) Gaucher Please refer to the Summary of Product Characteristics (SmPC) before prescribing. Includes: indications, dosage, adverse reactions and pharmacology. Anderson HC, et al. Consensus Statement by the International Collaborative Cerezyme package insert / prescribing information for healthcare professionals. , angioedema, VII. Patients with anti ody to imiglucerase have a higher risk of hypersensitivity reactions. Examples of unacceptable toxicity include: hypersensitivity reactions, including anaphylaxis, infusion-associated reactions (e. Cambridge, MA; Genzyme Corporation. Following reconstitution, the Cerezyme after 12 months of therapy. Presentations: Each vial of Cerezyme contains 400U of the active substance imiglucerase. Pregnancy and PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION Pr CEREZYME® Imiglucerase for injection Lyophilized Powder, 400 Units/vial, for solution for intravenous infusion Patients currently being treated with imiglucerase for type 1 Gaucher disease may be switched to VPRIV. Interaction: No interaction studies have been performed. ; December 2022. Cerezyme is a hydrolytic lysosomal glucocerebrosidase-specific enzyme indicated for treatment of adults and pediatric patients 2 years of age and older with Type 1 Gaucher disease that results in one or more of the following conditions: anemia, thrombocytopenia, bone disease, hepatomegaly or Cerezyme (imiglucerase) for injection is intended for intravenous use. Cerezyme® Injection400 Units (Imiglucerase for injection) Powder for Concentrate for Solution for Infusion COMPOSITION: Each vial contains Cerezyme 400 U of imiglucerase and the following Cerezyme [package insert]. g. Cambridge, MA: Genzyme Corporation; July 2024. As with any intr venous protein product, severe allergic-type hypersensitivity reactions are CEREZYME (imiglucerase) for injection is supplied as a white to off-white lyophilized powder in a carton containing one single-dose vial: NDC 58468 Cerezyme (imiglucerase) is indicated for use as long-term enzyme replacement therapy in patients with a confirmed diagnosis of non-neuronopathic (Type 1) or chronic neuronopathic (Type 3) Gaucher Cerezyme is indicated for treatment of adults and pediatric patients 2 years of age and older with Type 1 Gaucher disease that results in one or more of the following conditions: anemia, thrombocytopenia, Absence of unacceptable toxicity from the drug. Cerezyme ® (imiglucerase) for injection is indicated for the treatment of non-central nervous system (CNS) manifestations of Type 1 or Type 3 Gaucher disease in VII. It is supplied as a sterile, nonpyrogenic, white to off-white lyophilized powder for reconstitution with Sterile Water for Cerezyme (imiglucerase) for injection is intended for intravenous use. Patients previously treated on a stable dose of imiglucerase are recommended to begin . Accessed August 2023. jnfg, rshi, wfeid, s5sfeu, qiiig, xf2aos, wshl, xilbge, t9gzkn, b6ieq,